ChemicalBook > CAS DataBase List > Favipiravir

Favipiravir

Product Name
Favipiravir
CAS No.
259793-96-9
Chemical Name
Favipiravir
Synonyms
6-Fluoro-3-hydroxypyrazine-2-carboxamide;T-705;Favipiravi;6-fluoro-3,4-dihydro-3-oxo-Pyrazinecarboxamide;Avigan;Farapiwe;3-Dithian;Fapilawei;T-705,T705;3-Dithiane
CBNumber
CB71055246
Molecular Formula
C5H4FN3O2
Formula Weight
157.1
MOL File
259793-96-9.mol
More
Less

Favipiravir Property

Melting point:
>151°C (dec.)
Density 
1.78±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
solubility 
Soluble in DMSO (30 mg/mL), water (12 mg/mL with warming)
pka
8.77±0.60(Predicted)
form 
solid
color 
Off-white
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or water may be stored at -20° for up to 3 months.
InChI
InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)
InChIKey
ZCGNOVWYSGBHAU-UHFFFAOYSA-N
SMILES
C1(C(N)=O)=NC(F)=CNC1=O
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H341Suspected of causing genetic defects

Precautionary statements

P201Obtain special instructions before use.

P202Do not handle until all safety precautions have been read and understood.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P308+P313IF exposed or concerned: Get medical advice/attention.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
23384
Product name
T-705
Purity
≥98%
Packaging
50mg
Price
$85
Updated
2024/03/01
Cayman Chemical
Product number
23384
Product name
T-705
Purity
≥98%
Packaging
100mg
Price
$117
Updated
2024/03/01
Cayman Chemical
Product number
23384
Product name
T-705
Purity
≥98%
Packaging
5mg
Price
$98
Updated
2021/12/16
Cayman Chemical
Product number
23384
Product name
T-705
Purity
≥98%
Packaging
1mg
Price
$26
Updated
2021/12/16
Cayman Chemical
Product number
23384
Product name
T-705
Purity
≥98%
Packaging
10mg
Price
$34
Updated
2024/03/01
More
Less

Favipiravir Chemical Properties,Usage,Production

Description

Favipiravir, 6-fluoro-3-hydroxypyrazine-2-carboxamide, is a new broad-spectrum antiviral drug targeting RNA-dependent RNA polymerase (RdRp) developed by Japan's Toyama Chemical Pharmaceutical Company. It was approved for marketing in Japan in March 2014 for the treatment of new and recurrent influenza. During the outbreak of the new coronavirus, the results of the Phase I clinical study of the drug published in March 2020 showed that the drug may have the effect of speeding up virus clearance to alleviate the progress of new coronavirus pneumonia.

History

Favipiravir was originally developed in the late 1990s by a company that was later purchased by the Japanese firm Fujifilm as part of its transition from the photo business to healthcare. After being tested against a range of viruses, the drug was approved in Japan in 2014 for emergency use against flu epidemics or to treat new strains of influenza.

Uses

Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. It suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. Favipiravir can be used for antiviral treatment of influenza A and B. Studies have shown that in addition to influenza virus, the drug also exhibits good antiviral activity against a variety of RNA viruses, such as Ebola virus, arena virus, Bunia virus, rabies virus and now COVID-19.

Definition

ChEBI: Favipiravir is a member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6, respectively. It is an anti-viral agent that inhibits RNA-dependent RNA polymerase of several RNA viruses and is approved for the treatment of influenza in Japan. It has a role as an antiviral drug, an anticoronaviral agent and an EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor. It is a primary carboxamide, a hydroxypyrazine and an organofluorine compound.

Mechanism of action

Favipiravir is an antiviral drug that selectively inhibited the RdRP of influenza virus. It showed specific activity against all three influenza A, B, and C (Furuta et al., 2013). It also inhibited the RV replication in HeLa cells, with an EC50 of 29 μg/mL (Furuta et al., 2002). Analysis showed that the primary mechanism of action of favipiravir against the influenza virus was specific inhibition of vRNA polymerase (Furuta et al., 2005). It is predicted that a similar mechanism might occur with other viruses, such as PV and RV, inhibited by favipiravir, which may account for its broad-spectrum inhibition. Mechanistic studies show that the favipiravir and its form favipiravir-RMP (favipiravir-ribofuranosyl-50-monophosphate) do not inhibit influenza RNA polymerase activity, but it is the phosphoribosylated form, favipiravir-ribofuranosyl-50-triphosphate (RTP) that inhibits the enzyme.

Synthesis

Favipiravir was synthesized in only six steps from 3-aminopyrazine-2-carboxylic acid with an overall yield of about 22.3%. Key intermediates 3 and 6 were obtained in excellent purity via recrystallization from optimized solvents, which was beneficial to large-scale production. In the key synthetic reaction, 3,6-dichloropyrazine-2-carbonitrile (6) was reacted sequentially, in one pot, with KF and 30% H2O2 to give (after crystallization from 95% EtOH) favipiravir as colorless crystals, with a 60% yield for this final step of the synthesis. (DOI:10.1007/s11696-017-0208-6)

645 grams of sodium hydroxide were dissolved in 9L of water, the temperature was lowered to 5??C, and 1.29 kg of 6-fluoro-3-hydroxy-2-cyanopyrazine was added in batches, stirred, and heated slightly, and the temperature of the reaction system was controlled to -10??C, it takes 3.5 hours to complete the addition, after holding for 1 hour, the temperature is raised to 40??C for 1 hour. Add 100g of activated carbon to the reaction solution, hot filter, cool the mother liquor to 5??C, adjust the pH to 3-4 with concentrated hydrochloric acid, precipitate a large amount of solids, filter and dry to obtain a crude off-white powder, beaten with 2.8 liters of 15% methanol aqueous solution and filter After drying, 1.34 kg of white powder favipiravir was obtained. 1H-NMR (DMSO, 600MHz): |? 13.38 (s, 1H), 8.73 (1s, 1H), 8.51-8.49 (d, J=12, 2H) (yield 91%).

storage

Store at -20°C

References

[1] Y. FURUTA. In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705[J]. Antimicrobial Agents and Chemotherapy, 2002, 46 1: 977-981. DOI:10.1128/aac.46.4.977-981.2002
[2] KAZUMI TAKAHASHI. In vitro and in vivo activities of T-705 and oseltamivir against influenza virus.[J]. Antiviral Chemistry and Chemotherapy, 2003, 14 5: 235-241. DOI:10.1177/095632020301400502
[3] KATRINA SLEEMAN. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.[J]. Antimicrobial Agents and Chemotherapy, 2010, 54 6: 2517-2524. DOI:10.1128/aac.01739-09
[4] YOUSUKE FURUTA. Mechanism of action of T-705 against influenza virus.[J]. Antimicrobial Agents and Chemotherapy, 2005: 981-986. DOI:10.1128/aac.49.3.981-986.2005
[5] YOUSUKE FURUTA . Favipiravir (T-705), a novel viral RNA polymerase inhibitor[J]. Antiviral research, 2013, 100 2: Pages 446-454. DOI:10.1016/j.antiviral.2013.09.015
[6] LIYING DONG  Jianjun G  Shasha Hu. Discovering drugs to treat coronavirus disease 2019 (COVID-19).[J]. Drug Discoveries and Therapeutics, 2020, 14 1: 58-60. DOI:10.5582/ddt.2020.01012
[7] YUNG-FANG TU. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.[J]. International Journal of Molecular Sciences, 2020, 21 7. DOI:10.3390/ijms21072657

Favipiravir Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Favipiravir Suppliers

Jinan Wald Chemical Co., Ltd.
Tel
0531-88773586 13210588999
Fax
053188773586
Email
304264064@qq.com
Country
China
ProdList
195
Advantage
58
iangsu U-Liy Biotech Pharmaceuticals Inc
Tel
18021412923
Email
1515809609@qq.com
Country
China
ProdList
141
Advantage
58
Hangzhou Runyan Medical Technology Co., LTD
Tel
571-13989459766 18112526015
Email
sales@runyanpharma.com
Country
China
ProdList
471
Advantage
58
Jiangxi ravel Biotechnology Co.,Ltd
Tel
400-880-2824; 13184580281
Fax
400-880-2824
Email
hj@ruiweier.cn
Country
China
ProdList
2686
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
SiChuang NanBu Honesty Technology Co., Ltd.
Tel
0838-5675166 15883665058
Fax
0838-5675535
Email
nbcxkj@126.com
Country
China
ProdList
918
Advantage
55
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6003
Advantage
61
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Fax
+86-10-82967029
Email
2355560935@qq.com
Country
China
ProdList
12000
Advantage
60
Jia Xing Isenchem Co.,Ltd
Tel
0573-85285100 18627885956
Fax
0573-85285100
Email
isenchem@163.com
Country
China
ProdList
9310
Advantage
66
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Fax
021-64823266
Email
chenyj@titansci.com
Country
China
ProdList
14101
Advantage
59
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Country
China
ProdList
42934
Advantage
64
Shanghai Sphchem Co., Ltd.
Tel
021-56491756 13512199871
Fax
021-5649-1756
Email
2819742715@qq.com
Country
China
ProdList
4000
Advantage
55
Wuhan Fortuna Chemical Co., Ltd
Tel
027-59207852 13308628970
Fax
QQ3130921841
Email
buy@fortunachem.com
Country
China
ProdList
2744
Advantage
58
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Country
China
ProdList
4747
Advantage
58
Shanghai Hope Chem Co., Ltd.,
Tel
+21-18501659228 18501659228
Fax
sales@hope-chem.com
Email
info@hope-chem.com
Country
China
ProdList
474
Advantage
55
Changzhou Joyous Chemical Co., Ltd.
Tel
0519-85607258 13912342323;
Fax
0519-85607278
Email
sales@joyouschem.com
Country
China
ProdList
294
Advantage
60
ShangHai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847 13636370518
Fax
021-55068248
Email
shyysw007@163.com
Country
China
ProdList
4999
Advantage
60
SembCorp Shenzhenshibai a Biotechnology Co., Ltd
Tel
13412890622
Fax
0755-26737815/26017435-600
Country
China
ProdList
23
Advantage
55
Kohn & Shawn Pharmatech Co.,Ltd
Tel
0931-4190454 13893344397
Fax
+86-931-8506154
Email
sales@kyxpharma.com
Country
China
ProdList
310
Advantage
55
Tianjin Branch Chong pharmaceutical intermediates Co., Ltd.
Tel
022-60116533 13207668525
Fax
022-60979672
Email
saleskc@scipharmacn.com
Country
China
ProdList
603
Advantage
58
Hangzhou Sage Chemical Co., Ltd.
Tel
+86057186818502 13588463833
Fax
Pls mail us for more information!
Email
info@sagechem.com
Country
China
ProdList
10266
Advantage
58
Beijing Yisiyan Technology Research Center
Tel
010-56645598 13366904824
Fax
01062230033
Email
bjkaida@163.com
Country
China
ProdList
1618
Advantage
59
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Country
China
ProdList
9510
Advantage
58
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1493
Advantage
55
Acesys Pharmatech
Tel
18860950986
Email
tangmanman@zenjipharma.com
Country
China
ProdList
1733
Advantage
55
Shanghai MOF Chemical Tech Limited
Tel
13661494087 18964793018
Fax
86-021-51821718 QQ:2427604606
Email
sales@mof-chemicals.com
Country
China
ProdList
293
Advantage
55
Shanghai Yolne Chemical Co., Ltd.
Tel
021-62960152
Fax
021-52212593
Email
934678158@qq.com
Country
China
ProdList
9899
Advantage
55
Nanjing Dulai Biotechnology Co., Ltd.
Tel
025-846993838003-8003 18013301590
Fax
025-84699383-8003
Email
njduly@126.com
Country
China
ProdList
3249
Advantage
55
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
TargetMol Chemicals Inc.
Tel
021-021-33632979 15002134094
Fax
021-33632979
Email
marketing@targetmol.com
Country
China
ProdList
7782
Advantage
58
Wuhan HengHeDa Pharm Co., Ltd.
Tel
027-84888681 18086046872
Fax
027-84888682
Email
hhdpharm@hotmail.com
Country
China
ProdList
105
Advantage
55
CEG Chemical Science&Technology Co., Ltd.
Tel
Mobile:13665161512
Fax
+86-510-68873513
Country
China
ProdList
1785
Advantage
58
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Shanghai Hekang Biotechnology Co., Ltd.
Tel
18939837085
Fax
2880152141(QQ)
Email
youchemicals@gmail.com
Country
China
ProdList
1839
Advantage
55
ShangHai D&B Biological Science and Technology Co.Ltd
Tel
400-008-9730,021-54359730 400-008-9730
Fax
021-54353864
Email
info@chemxyz.com
Country
China
ProdList
3057
Advantage
60
Shanghai Worldyang Chemical Co.,Ltd.
Tel
021-021-56795766
Fax
+86-21-56795266
Email
sales@worldyachem.com
Country
China
ProdList
9476
Advantage
58
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
18333
Advantage
56
Finetech Industry Limited
Tel
027-87465837 19945049750
Fax
027-8777-2287
Email
sales@finetechnology-ind.com
Country
China
ProdList
9637
Advantage
58
Hunan HuaTeng Pharmaceutical Co., Ltd.,
Tel
400-8592883
Fax
0731-82251112
Email
sales@huatengsci.com
Country
China
ProdList
5872
Advantage
58
Wuhan Dahua Pharmaceutical Co., Ltd.
Tel
027-59262863 13277907145 3091977954
Fax
027-59420980
Country
China
ProdList
4942
Advantage
58
Hangzhou J&H Chemical Co., Ltd.
Tel
0571-87396432
Fax
0571-87396431
Email
sales@jhechem.com
Country
China
ProdList
14912
Advantage
59
Shanghai HuanChuan Industry Co.,Ltd.
Tel
021-61478794
Fax
021-61478794
Email
sales@hcshhai.com
Country
China
ProdList
9793
Advantage
50
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66028182 18626450290
Email
yftan@aikonchem.com
Country
China
ProdList
16679
Advantage
50
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Fax
025-68650336
Email
info@adooq.cn
Country
China
ProdList
2990
Advantage
60
LUCKY PHARMA CO., LIMITED
Tel
0571-86403260 86403970
Fax
0571-86403970
Email
lucky@lkbiology.com
Country
China
ProdList
243
Advantage
58
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
Fax
+86 (21) 6129-4103
Country
China
ProdList
9756
Advantage
58
Cool Pharm, Ltd
Tel
021-60455363 18019463053
Fax
50966098
Email
sales@coolpharm.com
Country
China
ProdList
12346
Advantage
58
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Chizhou Kailong Import and Export Trade Co., Ltd.
Tel
Fax
-
Email
xg01_gj@163.com
Country
China
ProdList
9484
Advantage
50
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4768
Advantage
55
More
Less

View Lastest Price from Favipiravir manufacturers

WUHAN FORTUNA CHEMICAL CO., LTD
Product
Favipiravir 259793-96-9
Price
US $0.00/Kg/Bag
Min. Order
10g
Purity
99%min HPLC
Supply Ability
10KGS
Release date
2021-07-02
Hebei Chuanghai Biotechnology Co., Ltd
Product
favipiravir 259793-96-9
Price
US $25.00/ASSAYS
Min. Order
100ASSAYS
Purity
99.5%
Supply Ability
100 mt
Release date
2024-11-20
Hebei Zhuanglai Chemical Trading Co Ltd
Product
Favipiravir 259793-96-9
Price
US $150.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
500kg
Release date
2024-12-24

259793-96-9, FavipiravirRelated Search:


  • Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo- (9CI)
  • Favipiravir
  • Unii-ew5gl2X7E0
  • 6-fluoro-3,4-dihydro-3-oxo-Pyrazinecarboxamide
  • 6-fluoro-3,4-dihydro-3-oxo- (9CI)
  • T-705
  • PYRAZINECARBOXAMIDE, 6-FLUORO-3,4-DIHYDRO-3-OXO-
  • 6-Fluoro-3-hydroxypyrazine-2-carboxamide
  • 2-PyrazinecarboxaMide, 6-fluoro-3,4-dihydro-3-oxo-
  • 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxaMide
  • PyrazinecarboxaMide, 6-fl...
  • T-705 favipiravir
  • T-705,T705
  • 6-Fluoro-3,4-dihydro-3-oxo-pyrazinecarboxaMide 95%
  • Favipiravi
  • Favipiravjr
  • T 705; FAVIPIRAVIR;T-705;T705
  • 5-fluoro-2-oxo-1H-pyrazine-3-carboxamide
  • 6-Fluoro-3-hydroxypyrazine-2-carboxamide favipiravir
  • Favipiravir(T-705)
  • Favipiravir API
  • 6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide
  • favipiravir 6-fluoro-3-hydroxypyrazine-2-carboxamide
  • The method of villa wei
  • Favipiravir (This product is unavailable in the U.S.)
  • 6-Fluoro-3-hydroxy-2-pyrazinecarboxamide
  • favipiravir USP/EP/BP
  • Fevipiravir
  • 5-Fluoro-2-oxo-1H-pyrazine-3-carboxamide, 95+%
  • Favipiravir D4Q: What is Favipiravir D4 Q: What is the CAS Number of Favipiravir D4
  • FAVIPIRAVIR (CAS 259793-96-9 )
  • 3-Dithiacyclohexane
  • 3-Dithian
  • 3-Dithiane
  • 5-Pyrimidinecarboxylicacid,4-chloro-3-(methylthio)-
  • Farapiwe
  • Fapilawei
  • Favipiravir (Antiprovir)
  • SARS-CoV,DNA/RNA Synthesis,Influenza Virus,T705,inhibit,SARS coronavirus,Favipiravir,Inhibitor,T 705
  • 6-Fluoro-3-hydroxy pyraine-2-carboxamide
  • Favipiravir In-House / IP
  • 6-Fluoro-3-hydroxypyrazine-2-formamide
  • Favipiravir In-House
  • Avigan
  • Favipiravir, 10 mM in DMSO
  • Favipiravir: 6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide
  • 259793-96-9
  • 201234-47-3
  • 259793-96-8
  • AMIDE
  • HALIDE
  • API
  • 259793-96-9